4 news items
Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
VXRT
13 Jun 24
control, including stability of the product candidate and quality assurance testing, shortages of qualified personnel or key raw materials
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
VXRT
13 May 24
difficulties with production costs and yields, quality control, including stability of the product candidate and quality assurance testing, shortages
12 Health Care Stocks Moving In Friday's After-Market Session
AEMD
AKAN
ATHE
10 May 24
(NASDAQ:AEMD) shares decreased by 5.09% to $1.12. The company's market cap stands at $2.9 million.
Assure
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VXRT
20 Mar 24
of the product candidate and quality assurance testing, shortages of qualified personnel or key raw materials, and compliance with strictly enforced
- Prev
- 1
- Next